Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis

• Үндсэн зохиолчид: Saharat Aungsumart (Зохиогч), Saowalak Turongkaravee (Зохиогч), Sitaporn Youngkong (Зохиогч), Metha Apiwattanakul (Зохиогч), Ammarin Thakkinstian (Зохиогч), Usa Chaikledkaew (Зохиогч)
• Формат: Ном
• Хэвлэсэн: BMC, 2023-10-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Background Multiple sclerosis is an inflammatory demyelination process in the central nervous system (CNS) causing neurological disability and poor quality of life. Currently, Thai Food and Drug Administration (FDA)-approved disease-modifying therapy is costly, and most patients with multip...